Pharmacokinetic Aspects of Palinavir, an HIV Protease Inhibitor, in Sprague

Pharmacokinetic Aspects of Palinavir, an HIV Protease Inhibitor, in Sprague–Dawley Rats

Published:1998-06 Issue:6 Volume:87 Page:782-786
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Liard Francine,Jaramillo Jorge,Paris William L.,Yoakim Christiane

Publisher

American Geophysical Union (AGU)

Subject

Pharmaceutical Science

Reference13 articles.

1. Antiviral Properties of Palinavir, a Potent Inhibitor of the Human Immunodeficiency Virus Type 1 Protease;Lamarre;Antimicrob. Agents Chemother.,1997

2. Anesthetic Uptake and Action;Eger,1975

3. Determination of the HIV Protease Inhibitor BILA 2185 BS in Rat Plasma by Liquid—Liquid Extraction and High Performance Liquid Chromatography Photodiode Array Detector;Liard;J. Pharm. Biomed. Anal.,1995

4. Heinzel, G.; Woloszezak R.; Thomann, P. TopFit Version 2.0. Pharmacokinetic and Pharmacodynamic Data Analysis System for the P.C. Dr. Karl Thomae GmbH. Schering Ag (Germany). Godeck AG, Gustav Fisher, Stuttgart, Jena, New York, 1993

5. Bioavailability Calculations for Drugs Showing Simultaneous First-Order and Capacity-Limited Elimination Kinetics;Martis;J. Pharmacokinet. Biopharm,1973

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Access to Enantioenriched 1,n-Diamines via Ni-Catalyzed Hydroamination of Unactivated Alkenes with Weakly Coordinating Groups;ACS Catalysis;2022-07-25

2. Macrocyclic Hepatitis C Virus NS3/4A Protease Inhibitors: An Overview of Medicinal Chemistry;Current Medicinal Chemistry;2016-10-17

3. Discovery and structural diversity of the hepatitis C virus NS3/4A serine protease inhibitor series leading to clinical candidate IDX320;Bioorganic & Medicinal Chemistry Letters;2015-11

4. Highly convergent stereoselective synthesis of chiral key intermediates in the synthesis of Palinavir from imines derived from l-glyceraldehyde;Tetrahedron;2002-01

5. Development of HIV protease inhibitors: A survey;Antiviral Agents;2001